BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

595 related articles for article (PubMed ID: 30867841)

  • 1. Microfluidic Isolation of Circulating Tumor Cells and Cancer Stem-Like Cells from Patients with Pancreatic Ductal Adenocarcinoma.
    Varillas JI; Zhang J; Chen K; Barnes II; Liu C; George TJ; Fan ZH
    Theranostics; 2019; 9(5):1417-1425. PubMed ID: 30867841
    [No Abstract]   [Full Text] [Related]  

  • 2. Enrichment with anti-cytokeratin alone or combined with anti-EpCAM antibodies significantly increases the sensitivity for circulating tumor cell detection in metastatic breast cancer patients.
    Deng G; Herrler M; Burgess D; Manna E; Krag D; Burke JF
    Breast Cancer Res; 2008; 10(4):R69. PubMed ID: 18687126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytometric characterization of circulating tumor cells captured by microfiltration and their correlation to the CellSearch(®) CTC test.
    Adams DL; Stefansson S; Haudenschild C; Martin SS; Charpentier M; Chumsri S; Cristofanilli M; Tang CM; Alpaugh RK
    Cytometry A; 2015 Feb; 87(2):137-44. PubMed ID: 25515318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patterns of circulating tumor cells identified by CEP8, CK and CD45 in pancreatic cancer.
    Zhang Y; Wang F; Ning N; Chen Q; Yang Z; Guo Y; Xu D; Zhang D; Zhan T; Cui W
    Int J Cancer; 2015 Mar; 136(5):1228-33. PubMed ID: 25042121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating Tumor Cells Expressing Markers of Tumor-Initiating Cells Predict Poor Survival and Cancer Recurrence in Patients with Pancreatic Ductal Adenocarcinoma.
    Poruk KE; Blackford AL; Weiss MJ; Cameron JL; He J; Goggins M; Rasheed ZA; Wolfgang CL; Wood LD
    Clin Cancer Res; 2017 Jun; 23(11):2681-2690. PubMed ID: 27789528
    [No Abstract]   [Full Text] [Related]  

  • 6. Circulating Tumor Cells Enriched by the Depletion of Leukocytes with Bi-Antibodies in Non-Small Cell Lung Cancer: Potential Clinical Application.
    Yin J; Wang Y; Yin H; Chen W; Jin G; Ma H; Dai J; Chen J; Jiang Y; Wang H; Liu Z; Hu Z; Shen H
    PLoS One; 2015; 10(8):e0137076. PubMed ID: 26317979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimization and Evaluation of a Novel Size Based Circulating Tumor Cell Isolation System.
    Xu L; Mao X; Imrali A; Syed F; Mutsvangwa K; Berney D; Cathcart P; Hines J; Shamash J; Lu YJ
    PLoS One; 2015; 10(9):e0138032. PubMed ID: 26397728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel method for downstream characterization of breast cancer circulating tumor cells following CellSearch isolation.
    Frithiof H; Welinder C; Larsson AM; Rydén L; Aaltonen K
    J Transl Med; 2015 Apr; 13():126. PubMed ID: 25896421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heterogeneous atypical cell populations are present in blood of metastatic breast cancer patients.
    Lustberg MB; Balasubramanian P; Miller B; Garcia-Villa A; Deighan C; Wu Y; Carothers S; Berger M; Ramaswamy B; Macrae ER; Wesolowski R; Layman RM; Mrozek E; Pan X; Summers TA; Shapiro CL; Chalmers JJ
    Breast Cancer Res; 2014 Mar; 16(2):R23. PubMed ID: 24602188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular detection of epithelial-mesenchymal transition markers in circulating tumor cells from pancreatic cancer patients: Potential role in clinical practice.
    Zhao XH; Wang ZR; Chen CL; Di L; Bi ZF; Li ZH; Liu YM
    World J Gastroenterol; 2019 Jan; 25(1):138-150. PubMed ID: 30643364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EpCAM-Independent Enrichment of Circulating Tumor Cells in Metastatic Breast Cancer.
    Schneck H; Gierke B; Uppenkamp F; Behrens B; Niederacher D; Stoecklein NH; Templin MF; Pawlak M; Fehm T; Neubauer H;
    PLoS One; 2015; 10(12):e0144535. PubMed ID: 26695635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EpCAM-independent isolation of circulating tumor cells with epithelial-to-mesenchymal transition and cancer stem cell phenotypes using ApoStream® in patients with breast cancer treated with primary systemic therapy.
    Le Du F; Fujii T; Kida K; Davis DW; Park M; Liu DD; Wu W; Chavez-MacGregor M; Barcenas CH; Valero V; Tripathy D; Reuben JM; Ueno NT
    PLoS One; 2020; 15(3):e0229903. PubMed ID: 32214335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A New Size-based Platform for Circulating Tumor Cell Detection in Colorectal Cancer Patients.
    Oh BY; Kim J; Lee WY; Kim HC
    Clin Colorectal Cancer; 2017 Sep; 16(3):214-219. PubMed ID: 28209483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Wedge-shaped microfluidic chip for circulating tumor cells isolation and its clinical significance in gastric cancer.
    Yang C; Zhang N; Wang S; Shi D; Zhang C; Liu K; Xiong B
    J Transl Med; 2018 May; 16(1):139. PubMed ID: 29792200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating Tumor Cells as a Biomarker in Pancreatic Ductal Adenocarcinoma.
    Liu H; Sun B; Wang S; Liu C; Lu Y; Li D; Liu X
    Cell Physiol Biochem; 2017; 42(1):373-382. PubMed ID: 28558380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of circulating tumor cell subpopulations in patients with head and neck squamous cell carcinoma (HNSCC).
    Weller P; Nel I; Hassenkamp P; Gauler T; Schlueter A; Lang S; Dountsop P; Hoffmann AC; Lehnerdt G
    PLoS One; 2014; 9(12):e113706. PubMed ID: 25479539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Baseline circulating stem-like cells predict survival in patients with metastatic breast Cancer.
    Lee CH; Hsieh JC; Wu TM; Yeh TS; Wang HM; Lin YC; Chen JS; Lee CL; Huang WK; Hung TM; Yen TT; Chan SC; Chou WC; Kuan FC; Hu CC; Chang PH
    BMC Cancer; 2019 Dec; 19(1):1167. PubMed ID: 31791269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical significance of circulating tumor cells after chemotherapy in unresectable pancreatic ductal adenocarcinoma.
    Kim H; Heo CM; Oh J; Chung HH; Lee EM; Park J; Lee SH; Lee KH; Lee KT; Lee JK; Cho YK; Park JK
    Transl Oncol; 2022 Feb; 16():101321. PubMed ID: 34954457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolation of Breast cancer CTCs with multitargeted buoyant immunomicrobubbles.
    Wang G; Benasutti H; Jones JF; Shi G; Benchimol M; Pingle S; Kesari S; Yeh Y; Hsieh LE; Liu YT; Elias A; Simberg D
    Colloids Surf B Biointerfaces; 2018 Jan; 161():200-209. PubMed ID: 29080504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enumeration and targeted analysis of KRAS, BRAF and PIK3CA mutations in CTCs captured by a label-free platform: Comparison to ctDNA and tissue in metastatic colorectal cancer.
    Kidess-Sigal E; Liu HE; Triboulet MM; Che J; Ramani VC; Visser BC; Poultsides GA; Longacre TA; Marziali A; Vysotskaia V; Wiggin M; Heirich K; Hanft V; Keilholz U; Tinhofer I; Norton JA; Lee M; Sollier-Christen E; Jeffrey SS
    Oncotarget; 2016 Dec; 7(51):85349-85364. PubMed ID: 27863403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.